Markets:

Overview

News

Currencies

International

Treasuries

Masimo Corporation - Common Stock (NQ:MASI)

178.59 +0.58 (+0.33%)

Streaming Delayed Price Updated: 4:00 PM EDT, Apr 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Masimo Corporation - Common Stock

< Previous 1 2

...

17 18 19 20 21 22 23 24 Next >

Why Jim Cramer Recommends Buying Norwegian Cruise Line ↗

March 03, 2022

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Norwegian Cruise Line Holdings Ltd. (NYSE...

Via Benzinga

Masimo's SedLine Brain Function Monitor Sensor Scores FDA Approval For Pediatric Use ↗

February 28, 2022

The FDA has FDA cleared Masimo Corp's (NASDAQ: MASI) SedLine brain function monitoring for pediatric patients (1-17 years of age) and the SedLine Pediatric EEG...

Via Benzinga

Masimo Announces FDA Clearance of Pediatric Indication for SedLine® Brain Function Monitoring and the SedLine Pediatric EEG Sensor

February 28, 2022

From Masimo

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For February 18, 2022 ↗

February 18, 2022

Upgrades Roth Capital upgraded the previous rating for Denbury Inc (NYSE:DEN) from Neutral to Buy. For the third quarter, Denbury had an EPS of $0.74, compared to year-ago...

Via Benzinga

Is Masimo 'Crazy Like A Fox' For Spending $1.03 Billion To Buy Sound United? ↗

February 16, 2022

Investors were left scratching their heads after Masimo announced the buyout.

Via Investor's Business Daily

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

February 17, 2022

Gainers Rhythm Pharmaceuticals (NASDAQ:RYTM) stock increased by 16.4% to $7.72 during Thursday's regular session. The current volume of 639.5K shares is 152.7% of...

Via Benzinga

56 Biggest Movers From Yesterday ↗

February 17, 2022

Gainers HOOKIPA Pharma Inc. (NASDAQ: HOOK) gained 54.5% to close at $2.07 on Wednesday. Hookipa Pharma amended and restated collaboration and license agreement with Gilead...

Via Benzinga

Masimo Whale Trades Spotted ↗

February 16, 2022

Someone with a lot of money to spend has taken a bullish stance on Masimo (NASDAQ:MASI). And retail traders should know. We noticed this today when the big position showed up on publicly available...

Via Benzinga

Mid-Afternoon Market Update: US Stocks Pare Losses; S&P 500 Turns Higher ↗

February 16, 2022

US stocks pared losses toward the end of trading on Wednesday following the release of Fed minutes.

Via Benzinga

MASI Stock: The Masimo-Sound United Deal That Has Investors Scratching Their Heads ↗

February 16, 2022

Masimo (MASI) stock is falling hard on Wednesday after the company revealed plans to acquire Sound United for a whopping $1.025 billion.

Via InvestorPlace

Mid-Day Market Update: Crude Oil Rises 2%; EIA Reports Unexpected Rise In Crude Inventories ↗

February 16, 2022

US stocks traded lower midway through trading on Wednesday ahead of the release of Fed minutes.

Via Benzinga

40 Stocks Moving In Wednesday's Mid-Day Session ↗

February 16, 2022

Gainers HOOKIPA Pharma Inc. (NASDAQ: HOOK) jumped 52.8% to $2.0478. Hookipa Pharma amended and restated collaboration and license agreement with Gilead Sciences for arenaviral...

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

February 16, 2022

On Wednesday, 115 companies reached new 52-week lows. Noteworthy Points From Today's 52-Week Lows: The largest company by market cap to hit a new 52-week low...

Via Benzinga

Mid-Morning Market Update: Markets Open Lower Ahead Of Fed Minutes ↗

February 16, 2022

US stocks opened on a downbeat note this morning following the release of several economic reports.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For February 16, 2022 ↗

February 16, 2022

Upgrades According to Compass Point, the prior rating for Comerica Inc (NYSE:CMA) was changed from Neutral to Buy. Comerica earned $1.66 in the fourth quarter, compared to $1.49...

Via Benzinga

Looking Into Masimo's Return On Capital Employed ↗

February 16, 2022

According to Benzinga Pro, during Q4, Masimo (NASDAQ:MASI) earned $68.26 million, a 18.15% increase from the preceding quarter. Masimo also posted a total of $327.58 million in sales, a 6.56% increase...

Via Benzinga

Masimo Stock Plunges After Q4 Results, Sound United Deal ↗

February 16, 2022

Masimo Corp's (NASDAQ: MASI) Q4 product revenue increased 11% Y/Y to $327.6 million, or 11.5% on a constant currency basis, beating the consensus of $320.93 million...

Via Benzinga

The Daily Biotech Pulse: Avenue Tumbles On Negative Adcom Verdict, Moderna's Expanded Deal With Rovi, Gilead Takes Equity Stake In Hookipa ↗

February 16, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Hookipa Gets $15M Upfront Payment And Equity Investment From Gilead Following...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

February 16, 2022

We've got another busy day of trading ahead of us so let's get right to it with the biggest pre-market stock movers for Wednesday!

Via InvestorPlace

10 Biggest Price Target Changes For Wednesday ↗

February 16, 2022

Needham raised Airbnb, Inc. (NASDAQ: ABNB) price target from $210 to $220. Airbnb shares rose 3.1% to $185.70 in pre-market trading.

Via Benzinga

Masimo: Q4 Earnings Insights ↗

February 15, 2022

Masimo (NASDAQ:MASI) reported its Q4 earnings results on Tuesday, February 15, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings Masimo beat estimated earnings by...

Via Benzinga

Sound United Enters into Agreement to Be Acquired by Masimo Corporation

February 15, 2022

From Sound United, LLC

Via Business Wire

Masimo Reports Fourth Quarter and Full-Year 2021 Financial Results and Announces Agreement to Acquire Sound United

February 15, 2022

From Masimo

Via Business Wire

The Daily Biotech Pulse: Larimar Plunges On Extension Of Clinical Hold, ImmunityBio Gains On Positive Data, Adcom Test Awaits Avenue Therapeutics ↗

February 15, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus ImmunityBio Says Cancer Combo Therapy Produces Positive Results In Late-Stage...

Via Benzinga

Earnings Scheduled For February 15, 2022 ↗

February 15, 2022

Companies Reporting Before The Bell • FirstService (NASDAQ:FSV) is estimated to report quarterly earnings at $1.31 per share on revenue of $1.07 billion.

Via Benzinga

A Preview Of Masimo's Earnings ↗

February 14, 2022

Masimo (NASDAQ:MASI) is set to give its latest quarterly earnings report on Tuesday, 2022-02-15. Here's what investors need to know before the announcement. Analysts estimate that Masimo will report an...

Via Benzinga

Masimo Adds Telehealth to Its SafetyNet® Telemonitoring System

February 10, 2022

From Masimo

Via Business Wire

Temple University Hospital Adopts Masimo Centroid™

February 07, 2022

From Masimo

Via Business Wire

7 Superior Stocks That Smart Investors Will Buy on the Dip ↗

February 07, 2022

The recent sell-off presents long-term investors with many robust stocks to buy on the dip. These seven provide a start.

Via InvestorPlace

Retrospective Study Finds That Masimo SET® Pulse Oximetry Has No Difference in Accuracy or Bias Between Black People and White People

January 17, 2022

From Masimo

Via Business Wire

< Previous 1 2

...

17 18 19 20 21 22 23 24 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.